Assessment of the Efficacy of a Neoadjuvant Combination: "Chemotherapy-targeted Therapy" in Breast Cancer.
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Cetuximab|DRUG: Docetaxel
Sponsor: Centre Jean Perrin
Collaborators: Merck Sharp & Dohme LLC|Sanofi